Naomi Biswas is a biotechnology intellectual property attorney with 25 years of patent and trademark portfolio management experience in both in-house and private practice roles. Since joining Patent GC in 2010, Naomi regularly provides strategic, business-focused counseling in all areas of her practice, including infringement analysis, portfolio development, licensing negotiation and transaction-related due diligence.
Naomi advises a broad array of clients, including start-up companies, universities, research foundations, and multinational corporations. Her areas of focus include genomics and post-genomics technologies, antibody engineering, small-molecule, biological, and nucleotide based therapeutics and a broad array of therapeutic areas including oncology, cardiovascular disease, metabolic disease, and CNS disorders. She has also advised clients in the chemical industry.
Previously, Naomi served as Director of Intellectual Property at Centeon (now CSL Behring), a multi-national pharmaceutical company specializing in blood plasma products and biologics. As lead U.S, patent attorney, Naomi oversaw the prosecution and management of CSL Behring’s international patent portfolio. She also worked closely with the senior management team to develop and implement patent strategies and manage all IP-related due diligence for licensing transactions, financings, and potential mergers and acquisitions. Naomi is a former partner in the intellectual property group of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo; and she began her legal career as an attorney at Synnestvedt & Lechner, a boutique intellectual property firm in Philadelphia.
Naomi received an AB in Molecular Biology from Princeton University and a JD from the University of Pennsylvania Law School where she was on law review.